J. Travis Hinson, M.D., utilizes genomic approaches like CRISPR/CAS to interrogate mechanisms of inherited cardiovascular disorders especially those that lead to heart failure. He is particularly interested in developing single cell and cardiac microtissue assays derived from disease-specific, human induced pluripotent stem cells (iPScs) in combination with in vivo mouse models. His lab’s current research focus is:
These studies capitalize on the Laboratory’s expertise in human genetics, stem cell biology, tissue engineering and computational methods. While my laboratory is at the Jackson Lababoratory, I also maintain a clinical practice treating patients with inherited cardiovascular diseases at the University of Connecticut Cardiology division.
DeLaughter DM, Bick AG, Wakimoto H, McKean D, Gorham JM, Kathiriya IS, Hinson JT, Homsy J, Gray J, Pu W, Bruneau BG, Seidman JG, Seidman CE. Single-Cell Resolution of Temporal Gene Expression during Heart Development. Dev Cell. pii: S1534-5807(16)30682-7. 2016.
Hinson JT, Chopra A, Nafissi N, Polacheck WJ, Benson CC, Swist S, Gorham J, Yang L, Schafer S, Sheng CC, Haghighi A, Homsy J, Hubner N, Church G, Cook SA, Linke WA, Chen CS, Seidman JG, Seidman CE. Titin mutations in iPS cells define sarcomere insufficiency as a cause of dilated cardiomyopathy. Science. 349(6251):982-6. 2015.
Hinson JT, Nakamura K, Wu SM. Induced pluripotent stem cell modeling of complex genetic diseases. Drug Discov Today Dis Models. 9(4):e147-e152. 2012.
Palmer BM, Wang Y, Teekakirikul P, Hinson JT, Fatkin D, Strouse S, Vanburen P, Seidman CE, Seidman JG, Maughan DW. Myofilament mechanical performance is enhanced by R403Q myosin in mouse myocardium independent of sex. Am J Physiol Heart Circ Physiol. 294(4):H1939-47. 2008.
Hinson JT, Fantin VR, Schönberger J, Breivik N, Siem G, McDonough B, Sharma P, Keogh I, Godinho R, Santos F, Esparza A, Nicolau Y, Selvaag E, Cohen BH, Hoppel CL, Tranebjaerg L, Eavey RD, Seidman JG, Seidman CE. Missense mutations in the BCS1L gene as a cause of the Björnstad syndrome. N Engl J Med. 356(8):809-19. 2007.
Klugherz BD, Song C, DeFelice S, Cui X, Lu Z, Connolly J, Hinson JT, Wilensky RL, Levy RJ. Gene delivery to pig coronary arteries from stents carrying antibody-tethered adenovirus. Hum Gene Ther. 13(3):443-54. 2002.
Patients who know they have a genetic predisposition to heart disease can take extra precautions and alert their health care providers to try to prevent symptoms before they occur.
Travis Hinson, M.D. discusses what his joint appointment with UConn Health and JAX means for his research into the genomic basis of cardiovascular disorders.
Physician-scientist J. Travis Hinson harnesses modern tools and technologies to unlock the biology of heart failure, laying the foundation for more precise, effective therapies.
In a paper published in Cell Reports, a team of researchers including JAX Assistant Professor Travis Hinson, M.D., report how they used human cell lines in addition to an animal model to study the mechanisms of the PRKAG2 mutation.
Dr. Travis Hinson, a joint faculty member at The Jackson Laboratory and UConn Health, discusses his work in cardiovascular genetics as both a physician and a scientist to advance translational medicine and enhance patient outcomes for heart diseases including cardiomyopathy and heart failure.
Utilizing genomic approaches to interrogate mechanisms of inherited cardiovascular disorders.
New JAX assistant professor Ryan Tewhey, PhD., explores genetic variants that affect gene regulation.
As 2015 comes to an end, a look back reveals tremendous progress in the precision medicine/clinical genomics space. This...
With over 80 years experience generating and characterizing mouse models, The Jackson Laboratory has enabled researchers to investigate...
Comparison of featured JAX® Mice for cardiovascular research
Clustered regularly interspaced short palindromic repeats.
Commentary presents the opportunities CRISPR provides to expand and improve the scope and clinical utility of mouse...
Have you ever wished that someone would make a knockout mouse of your favorite gene and tell you if there’s some kind of...
CRISPR/Cas9 techniques are quickly growing in popularity for the generation of new mouse models for research. Though the approach is...
Gene therapy is a promising strategy for treating patients suffering from X-linked Chronic Granulomatous Disease.
You’ve made a mutation using CRISPR/Cas9 Now what?
Browse videos, case studies, white papers, and more on CRISPR/Cas9 and JAX Model Generation Services.
Browse white papers and case studies on CRISPR/Cas9 and JAX Model Generation Services.
Browse on-demand videos on CRISPR/Cas9 and JAX Model Generation Services.